A Big Bet on Gene Therapy Is Just What Novartis AG (ADR) Stock Needs – Investorplace.com
Investorplace.com |
A Big Bet on Gene Therapy Is Just What Novartis AG (ADR) Stock Needs
Investorplace.com Respectfully, patients suffer from the disease but the potential revenue for treatment is limited. The hope for investors is that the clinical studies are successful in proving the safety and efficacy of gene therapy will lead to the development of … |
